Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$279.45 USD

279.45
7,041,273

-37.29 (-11.77%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 8% (232 out of 251)

Industry: Medical - HMOs

Better trading starts here.

Zacks News

Higher Optum Revenues to Drive UnitedHealth (UNH) Q4 Earnings

Increased contribution across Optum's segments should support UnitedHealth's (UNH) earnings in Q4.

    Mark Vickery headshot

    Top Research Reports for Wal-Mart, 3M & Union Pacific

    Today's Research Daily features new research reports on 16 major stocks, including Wal-Mart (WMT), 3M (MMM) and Union Pacific (UNP).

      Humana Extends Contract With Tivity Health, Spurs Healthcare

      Humana (HUM) continues to form strategic partnerships to improve the overall health of its Medicare Advantage members.

        The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint

        The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint

          3 Outperformers from Health Insurance in 2017

          The health insurance industry has witnessed regulatory uncertainties around Affordable Care Act, public exchange losses and inorganic growth in 2017.

            Can Walgreens' Retail Pharmacy USA Segment Drive Q1 Earnings?

            Walgreens Boots (WBA) rides high on strength in Retail Pharmacy USA division in fiscal 2017.

              Anthem Buys HealthSun to Expand Medicare Business in Florida

              Anthem's (ANTM) buyout of HealthSun reflects its long-term strategy to grow in the Medicare Advantage business.

                Humana-Kindred Deal Keeps Shakeout Alive in Healthcare Space

                Humana's (HUM) agreement to acquire Kindred at Home aligns with its strategy to grow vertically.

                  PBM Industry Shows Strength: 3 Stocks in Focus

                  Consider these three stocks for grand returns from the high-potential PBM market.

                    CVS-Aetna Deal: What's Hot, What's Not

                    CVS Health (CVS) and Aetna consolidation to add a new dimension to healthcare landscape. However, critics believe the gain will be short-lived for the healthcare society.

                      Humana Partners Einstein Healthcare for Value-Based Care

                      Humana (HUM) has been joining forces with other medical sector companies in order to strengthen its presence in value-based healthcare.

                        Humana's Medicare Business Impresses, Public Exchange Hurts

                        Although Humana (HUM) continues to grow on the back of Medicare and Medicaid expansions, threats from its exchange business weigh on both revenues and margins.

                          Can Health Insurers Continue to Look Past ACA Threats in Q4?

                          Despite regulatory challenges, health insurance companies have the potential to outperform in Q4 on growing demand for government plans, reduced uninsured rates and aging U.S. population.

                            Anthem (ANTM) Grows on Membership, Rising Expenses Hurt

                            Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.

                              The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel

                              The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel

                                Ensign Group (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y

                                Ensign Group's (ENSG) earnings missed estimates in Q3 but grew year over year due to higher revenues.

                                  Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss

                                  Humana's (HUM) strong third-quarter earnings were driven by significantly low share count.

                                    Anupama Mukhopadhyay headshot

                                    Humana's (HUM) Q3 Earnings Beat, Revenues Miss

                                    Humana's (HUM) third quarter earnings beat estimates but revenues miss expectations.

                                      Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?

                                      Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.

                                        Cigna (CI) Q3 Earnings Beat on Higher Enrollment, Guides Up

                                        Cigna's (CI) strong third-quarter earnings were driven by broad-based growth across its business segments.

                                          Will Increased Visits Drive Teladoc's (TDOC) Q3 Earnings?

                                          Teladoc's (TDOC) earnings will benefit from its premier consumer engagement capabilities, broad network and scalable platform, which will increase visits and clients.

                                            Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings?

                                            Envision Healthcare's (EVHC) third-quarter earnings are likely to see a drag from high expenses, partly offset by increased revenues from its physician services segment.

                                              Will Lower Health Care Revenues Mar Aetna (AET) Q3 Earnings?

                                              Aetna's (AET) third-quarter earnings are likely see a drain from lesser membership and low revenues in the Health Care segment, partly offset by benefits from share buyback and cost control.

                                                Will Higher Admissions Aid HCA Healthcare (HCA) Q3 Earnings?

                                                HCA Healthcare's (HCA) third-quarter earnings are likely to be benefited by its inorganic growth measures partly offset by industry weakness.

                                                  Can Admissions Rise Fuel Universal Health (UHS) Q3 Earnings?

                                                  Universal Health's (UHS) third-quarter results are likely to be driven by solid revenue growth in both its Acute Care and Behavioral Health segments.